A model for understanding patient attribution of adverse drug reaction symptoms

Drug Information Journal

Volumn 33, Issue 3, 1999, Pages 907-920

  DeWitt, Jane E ^a   Sorofman, Bernard A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adverse drug reaction; Illness representations; Symptoms

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; DECONGESTIVE AGENT; DIAGNOSTIC AGENT; GASTROINTESTINAL AGENT; HORMONE; HYPNOTIC SEDATIVE AGENT; MULTIVITAMIN; STEROID;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG UTILIZATION; EDUCATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PERCEPTION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECOGNITION; SELF REPORT; SYMPTOM; THEORY;

EID: 0032785442     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159903300332     Document Type: Article

References (37)

1. Gharaibeh MN, Greenberg HE, Waldman SA. Adverse drug reactions: A review. Drug Inf J. 1998; 32:323-338.
2. Kennedy DL, Johnson JM, Nightingale SL. Monitoring of adverse drug events in hospitals. JAMA. 1991; 266(20):287-288.
3. Venulet J, Berneker GC, Ciucci AG, eds. Assessing Causes of Adverse Drug Reactions. New York: Academic Press Inc; 1982.
4. Kellaway GSMcL. The patient. In: Inman WHW, ed. Monitoring for Drug Safety. Philadelphia: JB Lippincott Co.; 1980:543-554.
5. Bishop GD, Converse SA. Illness representations: A prototype approach. Health Psychol. 1986;5(2): 95-114.
6. Borden EK, Lee JG. A methodologic study of postmarketing drug evaluation using a pharmacy-based approach. J Chron Dis. 1982;35:803-816.
7. Luscombe FA. Methodologie issues in pharmacybased post-marketing surveillance. Drug Inf J. 1985; 19:269-274.
8. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Ping Kong HH. Frequency, severity and risk factors for adverse drug reactions in adult out-patients: A prospective study. J Chron Dis. 1986;39(7):533-542.
9. Campbell JPM, Howie JGR. Involving the patient in reporting adverse drug reactions. J R Coll Gen Pract. 1988;38:370-371.
10. Mellinger GD, Balter MB, Abramowitz S, Schaffer CB, Bernstein LR. Survey method for post-marketing drug surveillance: a demonstration. J Clin Psychopharmacol. 1988;8:168-176.
11. Rickels K, Downing RW. Side reactions in neurotics: II. Can patients judge which symptoms are caused by their medication? J Clin Pharmacol 1970;10(5): 298-305.
12. Morris LA, Kanouse DE. Informing patients about drug side effects. J Behav Med. 1982;5(3):363-373.
13. Van haecht CHM, VanderStichele R, Bogaert MG. Package inserts for antihypertensive drugs: Use by the patients and impact on adverse drug reactions. Eur J Clin Pharmacol. 1990;39:551-554.
14. Fisher S, Bryant SG, Solovitz BL, Kluge RM. A patient-initiated postmarketing surveillance system. Psychopharmacol Bull. 1987;23(3):400-404.
15. Fisher S, Bryant SG, Kluge RM. New approaches to postmarketing surveillance. Psychopharmacol. 1986;90:347-350.
16. Solovitz BL, Fisher S, Bryant SG, Kluge RM. How well can patients discriminate drug-related side effects from extraneous new symptoms? Psychopharmacol Bull. 1987;23(1):189-192.
17. Fisher S, Bryant SG. Postmarketing surveillance: Accuracy of patient drug attribution judgments. Clin Pharmacol Ther. 1990;48:102-107.
18. Bryant SG, Fisher S, Larson DB, Olins NJ. Age effects on patient drug attribution judgments. J Aging Health. 1992;2:101-111.
19. O'Brien BJ, Elswood J, Calin A. Perception of prescription drug risks: A survey of patients with ankylosing spondylitis. J Rheumatol. 1990;17:503-507.
20. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use. Ann Intern Med. 1992;117:634-640.
21. Rodin J, Salovey P. Health Psychology. In: Rosenzweig MR, Porter LW, eds. Annual Review of Psychology. Palo Alto: Annual Reviews, Inc.; 1989: 533-579.
22. Pennebaker JW, Skelton JA. Psychological parameters of physical symptoms. Personal Soc Psychol Bull. 1978;4(4):524-530.
23. Pennebaker JW, Skelton JA. Selective monitoring of bodily sensations. J Pers Soc Psychol. 1981;41: 213-223.
24. Pennebaker JW. The Psychology of Physical Symptoms. New York: Springer-Verlag; 1982.
25. Mechanic D, ed. Symptoms, Illness Behavior, and Help-seeking. New York: Prodist; 1982.
26. Kasl SV, Cobb S. Health behavior, illness behavior and sick role behavior. Arch Environ Health. 1966; 12:246-266.
27. Kleinman A. Patients and healers in the context of culture. In: Leslie C, ed. Comparative Studies of Health Systems and Medical Care. Berkeley: University of California Press; 1980.
28. Leventhal H, Nerenz D, Straus A. Self-regulation and the mechanisms for symptom appraisal. In: Mechanic D, ed. Symptoms, Illness Behavior, and Help-seeking. New York: Prodist; 1982:55-86.
29. Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, ed. Contributions to Medical Psychology. Oxford: Pergamon; 1980:7-30.
30. Lau RR, Hartman KA. Common sense representations of common illnesses. Health Psych. 1983;2(2): 167-185.
31. Lau RR, Bernard TM, Hartman KA. Further explorations of common-sense representations of common illnesses. Health Psych. 1989;8(2):195-219.
32. Bishop GD, Briede C, Cavazos L, Grotzinger R, McMahon S. Processing illness information: the role of disease prototypes. Basic Appl Soc Psych. 1987; 8(1 & 2):21-43.
33. American Society of Health-System Pharmacists. AHFS Drug Information 97. Bethesda, MD: American Society of Health-System Pharmacists, Inc; 1997.
34. SPSS-X User's Guide. 3rd edition. Chicago: SPSS Inc; 1988.
35. Food and Drug Administration Annual Adverse Drug Experience Report 1996. http://www.fda.gov/ cder/dpe/annrep96/index.htm (Oct 30, 1997).
36. Faich GA, Dreis M, Tomita D. National adverse drug reaction surveillance. Arch Intern Med. 1988; 148:785-787.
37. Milstien JB, Faich GA, Hsu JP, Knapp DE, Baum C, Dreis MW. Factors affecting physician reporting of adverse drug reactions. Drug Inf J. 1986;20:157-164.